Metastasis Directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-Resistant Prostate Cancer

被引:0
|
作者
Deek, M. P. [1 ]
Taparra, K. [2 ]
Phillips, R. [1 ]
Velho, P. Isaacsson [1 ]
Gao, R. W. [3 ]
Deville, C., Jr. [1 ]
Song, D. [4 ]
Greco, S. C. [4 ]
Carducci, M. [1 ]
Eisenberger, M. [1 ]
DeWeese, T. L. [4 ]
Denmeade, S. [1 ]
Pienta, K. [5 ]
Paller, C. [1 ]
Antonarakis, E. S. [1 ]
Olivier, K. [6 ]
Park, S. S. [6 ]
Tran, P. T. [4 ]
Stish, B. J. [6 ]
机构
[1] Johns Hopkins Med, Baltimore, MD USA
[2] Mayo Clin, Alix Sch Med, Rochester, MN USA
[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[4] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA
[6] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4079
引用
收藏
页码:E893 / E894
页数:2
相关论文
共 50 条
  • [1] Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
    Deek, Matthew P.
    Taparra, Kekoa
    Phillips, Ryan
    Velho, Pedro Isaacsson
    Gao, Robert W.
    Deville, Curtiland
    Song, Daniel Y.
    Greco, Stephen
    Carducci, Michael
    Eisenberger, Mario
    DeWeese, Theodore L.
    Denmeade, Samuel
    Pienta, Kenneth
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    Olivier, Kenneth R.
    Park, Sean S.
    Tran, Phuoc T.
    Stish, Bradley J.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 447 - 455
  • [2] Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer
    Lee, Jun Nyung
    Kim, Mi Young
    Kang, Jae Hoon
    Kang, Jun-Koo
    Chung, Jae-Wook
    Ha, Yun-Sok
    Choi, Seock Hwan
    Kim, Bum Soo
    Kim, Hyun Tae
    Kim, Tae-Hwan
    Yoo, Eun Sang
    Kim, See Hyung
    Kwon, Tae Gyun
    INVESTIGATIVE AND CLINICAL UROLOGY, 2024, 65 (02) : 132 - 138
  • [3] Metastasis-directed therapy for oligoprogressive castration refractory prostate cancer
    Berghen, C.
    Joniau, S.
    Ost, P.
    Poels, K.
    Everaerts, W.
    Haustermans, K.
    De Meerleer, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S451 - S451
  • [4] The efficacy of metastasis-directed radiation therapy (MDRT) for oligometastatic castration-resistant prostate cancer (CRPC)
    Nagahara, Akira
    Kanaki, Tomohiro
    Yamamoto, Akinaru
    Yamamoto, Yoshiyuki
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Konishi, Koji
    Teshima, Teruki
    Nishimura, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer
    Kawai, Taketo
    Taguchi, Satoru
    Nozaki, Keina
    Kimura, Naoki
    Oshina, Takahiro
    Iwaki, Takuya
    Matsui, Hotaka
    Niimi, Aya
    Kamei, Jun
    Akiyama, Yoshiyuki
    Yamada, Yuta
    Sato, Yusuke
    Yamada, Daisuke
    Kaneko, Tomoyuki
    Sawayanagi, Subaru
    Nakayama, Hidetsugu
    Minamimoto, Ryogo
    Yamashita, Hideomi
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Kume, Haruki
    PROSTATE INTERNATIONAL, 2023, 11 (04) : 239 - 246
  • [6] Castration-resistant prostate cancer: systemic therapy in 2012
    Maluf, Fernando C.
    Smaletz, Oren
    Herchenhorn, Daniel
    CLINICS, 2012, 67 (04) : 389 - 394
  • [7] Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
    Triggiani, Luca
    Mazzola, Rosario
    Magrini, Stefano Maria
    Ingrosso, Gianluca
    Borghetti, Paolo
    Trippa, Fabio
    Lancia, Andrea
    Detti, Beatrice
    Francolini, Giulio
    Matrone, Fabio
    Bortolus, Roberto
    Fanetti, Giuseppe
    Maranzano, Ernesto
    Pasqualetti, Francesco
    Paiar, Fabiola
    Bonu, Marco Lorenzo
    Magli, Alessandro
    Bruni, Alessio
    Mazzeo, Ercole
    Franzese, Ciro
    Scorsetti, Marta
    Alongi, Filippo
    Jereczek-Fossa, Barbara Alicja
    Ost, Piet
    Buglione, Michela
    WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2631 - 2637
  • [8] Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
    Luca Triggiani
    Rosario Mazzola
    Stefano Maria Magrini
    Gianluca Ingrosso
    Paolo Borghetti
    Fabio Trippa
    Andrea Lancia
    Beatrice Detti
    Giulio Francolini
    Fabio Matrone
    Roberto Bortolus
    Giuseppe Fanetti
    Ernesto Maranzano
    Francesco Pasqualetti
    Fabiola Paiar
    Marco Lorenzo Bonù
    Alessandro Magli
    Alessio Bruni
    Ercole Mazzeo
    Ciro Franzese
    Marta Scorsetti
    Filippo Alongi
    Barbara Alicja Jereczek-Fossa
    Piet Ost
    Michela Buglione
    World Journal of Urology, 2019, 37 : 2631 - 2637
  • [9] Metastasis-Directed Therapy for Oligoprogressive Castration-Resistant Prostate Cancer - Preliminary Results of the Prospective, Single-Arm MEDCARE Trial
    Berghen, C.
    Joniau, S.
    Rans, K.
    Poels, K.
    Devos, G.
    Haustermans, K.
    Goffin, K.
    De Meerleer, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E265 - E266
  • [10] Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
    Kitajima, Kazuhiro
    Yamamoto, Shingo
    Fujiwara, Masayuki
    Suzuki, Hitomi
    Yoshimura, Nahomi
    Kunimoto, Ryo
    Yokoyama, Hiroyuki
    Komoto, Hisashi
    Yamada, Yusuke
    Nagasawa, Seiji
    Kanematsu, Akihiro
    Oh, Ryoong-Jin
    Yamakado, Koichiro
    CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 13 - 16